Experts link tamoxifen use to diabetes in breast cancer survivors

10/3/2011 | PhysiciansBriefing.com

A study of 14,360 early-stage breast cancer survivors showed that 10% of patients who had tamoxifen treatment developed diabetes during a mean follow-up time of 5.2 years. The findings suggest that tamoxifen may worsen an underlying diabetes risk in susceptible women, researchers reported in the journal Cancer.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC